VJOncology is committed to improving our service to you

ESMO 2018 | The need to differentiate between low- and high-grade ovarian cancer

VJOncology is committed to improving our service to you

Jalid Sehouli

Jalid Sehouli, MD, of the Charité University of Medicine Berlin, Berlin, Germany, shares his concern for the lack of guidelines in low-grade ovarian cancer management at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany. Prof. Sehouli highlights the results from his survey involving a number of institutions, and expresses the need for stratification of studies on low-grade as well as high-grade ovarian cancers, in order to develop a guideline of recommendations on treatment strategies tailored to the particular grading.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter